Weight suppression and weight rebound in ex-smokers treated with fluoxetine

Belinda Borrelli, Bonnie Spring, Raymond Niaura, Jean Kristeller, Judith K. Ockene, Nancy J. Keuthen

Research output: Contribution to journalArticle

Abstract

Fluoxetine's effect (30 mg, 60 mg, and placebo) on postcessation weight gain was Studied among participants from a randomized, double-blind 10-week smoking cessation trial who met strict criteria for abstinence and drag levels. It was hypothesized that (a) fluoxetine would dose-dependently suppress postcessation weight gain and (b) drug discontinuation would produce dose-dependent weight rebound. During the on-drug phase, placebo participants gained weight linearly (M = 2.61 kg), exceeding both fluoxetine groups (30- mg group M = 1.33 kg, 60-mg group M = 1.25 kg). Weight suppression was initially greater for 60 mg than 30 mg, but both were followed by weight gain. Six months off drag produced greater dose-dependent weight rebound for 60 mg than 30 mg or placebo. Considering both on- and off-drug phases, weight gain for 60 mg of fluoxetine (M = 6.5 kg) was comparable with that for placebo (M = 4.7 kg) but greater than that for 30 mg (M := 3.6 kg). Fluoxetine appears to forestall postcessation weight gain, allowing time for the weight-conscious smoker to focus on quitting smoking rather than on preventing weight gain.

Original languageEnglish (US)
Pages (from-to)124-131
Number of pages8
JournalJournal of Consulting and Clinical Psychology
Volume67
Issue number1
DOIs
StatePublished - 1999

Fingerprint

Fluoxetine
Weight Gain
Weights and Measures
Placebos
Pharmaceutical Preparations
Smoking Cessation
Suppression
Smoking

ASJC Scopus subject areas

  • Clinical Psychology
  • Arts and Humanities (miscellaneous)
  • Psychiatry and Mental health

Cite this

Weight suppression and weight rebound in ex-smokers treated with fluoxetine. / Borrelli, Belinda; Spring, Bonnie; Niaura, Raymond; Kristeller, Jean; Ockene, Judith K.; Keuthen, Nancy J.

In: Journal of Consulting and Clinical Psychology, Vol. 67, No. 1, 1999, p. 124-131.

Research output: Contribution to journalArticle

Borrelli, Belinda ; Spring, Bonnie ; Niaura, Raymond ; Kristeller, Jean ; Ockene, Judith K. ; Keuthen, Nancy J. / Weight suppression and weight rebound in ex-smokers treated with fluoxetine. In: Journal of Consulting and Clinical Psychology. 1999 ; Vol. 67, No. 1. pp. 124-131.
@article{06c04caeffa542feaaaf4d2bf83b448c,
title = "Weight suppression and weight rebound in ex-smokers treated with fluoxetine",
abstract = "Fluoxetine's effect (30 mg, 60 mg, and placebo) on postcessation weight gain was Studied among participants from a randomized, double-blind 10-week smoking cessation trial who met strict criteria for abstinence and drag levels. It was hypothesized that (a) fluoxetine would dose-dependently suppress postcessation weight gain and (b) drug discontinuation would produce dose-dependent weight rebound. During the on-drug phase, placebo participants gained weight linearly (M = 2.61 kg), exceeding both fluoxetine groups (30- mg group M = 1.33 kg, 60-mg group M = 1.25 kg). Weight suppression was initially greater for 60 mg than 30 mg, but both were followed by weight gain. Six months off drag produced greater dose-dependent weight rebound for 60 mg than 30 mg or placebo. Considering both on- and off-drug phases, weight gain for 60 mg of fluoxetine (M = 6.5 kg) was comparable with that for placebo (M = 4.7 kg) but greater than that for 30 mg (M := 3.6 kg). Fluoxetine appears to forestall postcessation weight gain, allowing time for the weight-conscious smoker to focus on quitting smoking rather than on preventing weight gain.",
author = "Belinda Borrelli and Bonnie Spring and Raymond Niaura and Jean Kristeller and Ockene, {Judith K.} and Keuthen, {Nancy J.}",
year = "1999",
doi = "10.1037/0022-006X.67.1.124",
language = "English (US)",
volume = "67",
pages = "124--131",
journal = "Journal of Consulting and Clinical Psychology",
issn = "0022-006X",
publisher = "American Psychological Association Inc.",
number = "1",

}

TY - JOUR

T1 - Weight suppression and weight rebound in ex-smokers treated with fluoxetine

AU - Borrelli, Belinda

AU - Spring, Bonnie

AU - Niaura, Raymond

AU - Kristeller, Jean

AU - Ockene, Judith K.

AU - Keuthen, Nancy J.

PY - 1999

Y1 - 1999

N2 - Fluoxetine's effect (30 mg, 60 mg, and placebo) on postcessation weight gain was Studied among participants from a randomized, double-blind 10-week smoking cessation trial who met strict criteria for abstinence and drag levels. It was hypothesized that (a) fluoxetine would dose-dependently suppress postcessation weight gain and (b) drug discontinuation would produce dose-dependent weight rebound. During the on-drug phase, placebo participants gained weight linearly (M = 2.61 kg), exceeding both fluoxetine groups (30- mg group M = 1.33 kg, 60-mg group M = 1.25 kg). Weight suppression was initially greater for 60 mg than 30 mg, but both were followed by weight gain. Six months off drag produced greater dose-dependent weight rebound for 60 mg than 30 mg or placebo. Considering both on- and off-drug phases, weight gain for 60 mg of fluoxetine (M = 6.5 kg) was comparable with that for placebo (M = 4.7 kg) but greater than that for 30 mg (M := 3.6 kg). Fluoxetine appears to forestall postcessation weight gain, allowing time for the weight-conscious smoker to focus on quitting smoking rather than on preventing weight gain.

AB - Fluoxetine's effect (30 mg, 60 mg, and placebo) on postcessation weight gain was Studied among participants from a randomized, double-blind 10-week smoking cessation trial who met strict criteria for abstinence and drag levels. It was hypothesized that (a) fluoxetine would dose-dependently suppress postcessation weight gain and (b) drug discontinuation would produce dose-dependent weight rebound. During the on-drug phase, placebo participants gained weight linearly (M = 2.61 kg), exceeding both fluoxetine groups (30- mg group M = 1.33 kg, 60-mg group M = 1.25 kg). Weight suppression was initially greater for 60 mg than 30 mg, but both were followed by weight gain. Six months off drag produced greater dose-dependent weight rebound for 60 mg than 30 mg or placebo. Considering both on- and off-drug phases, weight gain for 60 mg of fluoxetine (M = 6.5 kg) was comparable with that for placebo (M = 4.7 kg) but greater than that for 30 mg (M := 3.6 kg). Fluoxetine appears to forestall postcessation weight gain, allowing time for the weight-conscious smoker to focus on quitting smoking rather than on preventing weight gain.

UR - http://www.scopus.com/inward/record.url?scp=0344937948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0344937948&partnerID=8YFLogxK

U2 - 10.1037/0022-006X.67.1.124

DO - 10.1037/0022-006X.67.1.124

M3 - Article

VL - 67

SP - 124

EP - 131

JO - Journal of Consulting and Clinical Psychology

JF - Journal of Consulting and Clinical Psychology

SN - 0022-006X

IS - 1

ER -